Nuvation Bio

Nuvation Bio

Yahoo Finance • 24 days ago

Sector Update: Healthcare Stocks Rise Thursday Afternoon

Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index adding 0.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

Jim Cramer sends strong 5-word message on surging biotech stock

Jim Cramer openly shares his opinions about various stocks, and on September 3, 2026, during an episode of CNBC's Mad Money, he gave his two cents on Nuvation Bio (NUVB). A caller asked about the surging biopharma name, and Cramer answere... Full story

Yahoo Finance • 2 months ago

Nuvation Bio Q2 Earnings Call Highlights

Key Points Interested in Nuvation Bio Inc.? Here are five stocks we like better. IBTROZI momentum strengthened: Second-quarter revenue reached $31.7 million, including $23.2 million in U.S. product revenue, up 25% sequentially. About 85%... Full story

Yahoo Finance • 3 months ago

Can Nuvation Bio Inc (NUVB) Stock Soar 150% From Current Level?

Nuvation Bio Inc (NYSE:NUVB) is one of billionaire David Abrams' top stock picks with upside potential. Nuvation Bio shares gained nearly 170% over the past year, and analysts project a more than 150% upside for the stock over the next 12... Full story

Yahoo Finance • 4 months ago

Nuvation Bio Prices Upsized $250 Mln Offering Of Convertible Notes; Stock Down

(RTTNews) - Nuvation Bio Inc. (NUVB), an oncology company, priced an upsized offering of $250 million aggregate principal amount of 0.75% convertible senior notes due in 2032. The aggregate principal amount was increased from the previousl... Full story

Yahoo Finance • 4 months ago

Nuvation Bio prices $250M convertible notes offering

* Global oncology company Nuvation Bio (NUVB [https://seekingalpha.com/symbol/NUVB]) announced Friday the pricing of an upsized underwritten offering of $250M aggregate principal amount of 0.75% Convertible Senior Notes due 2032. * The... Full story

Yahoo Finance • 4 months ago

Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum

Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains. On June 9, 2026, Director Robert Mashal reported the acquisition of 25,000 shares of Nuvation Bio... Full story

Yahoo Finance • 5 months ago

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.

Investor Stanley Druckenmiller’s Duquesne Family Office exited a 385,000 share position in Alphabet in the first quarter. Continue Reading... Full story

Yahoo Finance • 5 months ago

Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer

Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States Move by Nuvation Bio further ensures critical drug supply for patients and providers NEW YORK, May 13,... Full story

Yahoo Finance • 5 months ago

Nuvation Bio's Supplemental NDA With Updated Data For IBTROZI Wins FDA Acceptance

(RTTNews) - Wednesday, Nuvation Bio Inc. (NUVB) announced that the U.S. Food and Drug Administration has accepted a supplemental New Drug Application with updated data for IBTROZI for the treatment of advanced ROS1-positive non-small cell... Full story

Yahoo Finance • 6 months ago

Nuvation Bio Inc (NUVB): Take a Look at Glioma Revenue Potential

Nuvation Bio Inc (NYSE:NUVB) is among the must-buy penny stocks to invest in now. RBC Capital analysts see bright prospects for Nuvation Bio Inc (NYSE:NUVB) in the glioma treatment market, which they say is underserved. On April 6, RBC Cap... Full story

Yahoo Finance • 6 months ago

How Much Can Nuvation Bio (NUVB) Make From Ibtrozi Sales?

Nuvation Bio Inc. (NYSE:NUVB) is one of the best stock picks of billionaire David Abrams. Nuvation Bio Inc. (NYSE:NUVB) is also a favorite on the Street. The stock carries a Strong Buy rating with an average price target of $11.93, which i... Full story

Yahoo Finance • 6 months ago

Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks

Nuvation Bio Inc. (NYSE:NUVB) is one of the best healthcare penny stocks to buy according to hedge funds. On April 8, analysts at Truist Securities reiterated a Buy rating on Nuvation Bio Inc (NYSE:NUVB) with a $12 price target. The positi... Full story

Yahoo Finance • 6 months ago

FDA Priority Review And New Alliances Reshape Daiichi Sankyo Growth Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The FDA has accepted a Priority Review for Daiichi Sankyo and Merck’s biologics license application for ifinatamab deruxtec... Full story

Yahoo Finance • 6 months ago

Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights

Nuvation Bio Inc. (NYSE:NUVB) secures a spot on our list of the best penny stocks set to explode.Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights As of April 8, 2026, over 90% of covering analysts maintain their “... Full story

Yahoo Finance • 6 months ago

Nuvation Bio Inc. (NUVB) and Eisai Get EMA Validation for Taletrectinib

Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Stocks Under $10 to Buy and Hold Forever. On March 27, Nuvation Bio Inc. (NYSE:NUVB) and Eisai announced that the European Medicines Agency (EMA) validated the Marketing Authorisation Applic... Full story

Yahoo Finance • 7 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nuvation Bio Inc. (“Nuvation” or the “Company”) (NYSE: NUVB).  Such investors are advised to contact Danielle Peyton at newactio... Full story

Yahoo Finance • 7 months ago

Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch

Nuvation Bio Inc. (NYSE:NUVB) is one of the best low cost stocks to buy under $5. On March 2, Nuvation Bio (NUVB) reported a pivotal 2025 marked by the FDA approval and rapid commercial launch of Ibtrozi (Taletrectinib) for ROS1-positive n... Full story

Yahoo Finance • 7 months ago

Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Nuvation Bio Inc. (NYSE: NUVB). The investigation focuses on whether Nuvation Bio and its executive officers c... Full story

Yahoo Finance • 7 months ago

SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction

Key Points Knoll Capital Management bought 245,000 shares of SSR Mining. The quarter-end value of the SSR Mining position increased by $5.37 million due to the new purchase. The new SSR Mining position represents 2.46% of Knoll Capital Ma... Full story